Limpid Markets
← Back to Intelligence

IDEAYA Biosciences stock surges 27% on trial results

Investing.com Gold Tier 2 2026-04-13 10:57 UTC 📖 1 min read Neutral

Investing.com Gold reports: IDEAYA Biosciences stock surges 27% on trial results. Full body text was unavailable at ingest time, so this brief is based on headline context.

↗ Read Original